Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 5,814 shares of the stock in a transaction on Wednesday, May 20th. The shares were bought at an average cost of $4.39 per share, for a total transaction of $25,523.46. Following the purchase, the president directly owned 15,914 shares of the company’s stock, valued at $69,862.46. The trade was a 57.56% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora acquired 6,420 shares of Auna stock. The shares were bought at an average cost of $4.15 per share, for a total transaction of $26,643.00.
- On Thursday, May 28th, Leon Jesus Zamora acquired 9,220 shares of Auna stock. The shares were bought at an average cost of $4.17 per share, for a total transaction of $38,447.40.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 30,000 shares of Auna stock. The shares were bought at an average cost of $4.39 per share, for a total transaction of $131,700.00.
- On Wednesday, May 27th, Leon Jesus Zamora acquired 23,273 shares of Auna stock. The shares were bought at an average cost of $4.20 per share, for a total transaction of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 8,727 shares of Auna stock. The shares were bought at an average cost of $4.24 per share, for a total transaction of $37,002.48.
Auna Trading Up 9.4%
NYSE AUNA traded up $0.39 on Monday, reaching $4.54. 482,885 shares of the company were exchanged, compared to its average volume of 388,856. The business’s fifty day moving average price is $5.20 and its 200 day moving average price is $5.01. The stock has a market capitalization of $336.01 million, a P/E ratio of 17.46 and a beta of 0.82. The company has a current ratio of 1.09, a quick ratio of 1.00 and a debt-to-equity ratio of 1.76. Auna S.A. has a fifty-two week low of $4.09 and a fifty-two week high of $6.85.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Wall Street Zen lowered Auna from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research note on Friday, March 27th. JPMorgan Chase & Co. decreased their price target on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Finally, Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Auna has an average rating of “Hold” and a consensus price target of $6.97.
View Our Latest Report on AUNA
Institutional Investors Weigh In On Auna
Institutional investors and hedge funds have recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in shares of Auna in the 3rd quarter valued at $75,000. Bank of America Corp DE raised its holdings in shares of Auna by 255.9% in the 1st quarter. Bank of America Corp DE now owns 16,886 shares of the company’s stock valued at $93,000 after buying an additional 12,142 shares during the period. Renaissance Technologies LLC raised its holdings in shares of Auna by 487.7% in the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after buying an additional 554,707 shares during the period. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Auna in the 1st quarter valued at $316,000. Finally, Lazard Asset Management LLC purchased a new stake in shares of Auna in the 1st quarter valued at $557,000.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Read More
- Five stocks we like better than Auna
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
